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The 7-valent pneumococcal conjugate vaccine (PCV7) reduces carriage of vaccine type Streptococcus pneumoniae but leads to
replacement by nonvaccine serotypes andmay affect carriage of other respiratory pathogens. We investigated nasopharyngeal
carriage of S. pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and Staphylococcus aureus in Fijian infants partici-
pating in a pneumococcal vaccine trial using quantitative PCR. Vaccination did not affect pathogen carriage rates or densities,
whereas significant differences between the twomajor ethnic groups were observed.
Nasopharyngeal (NP) carriage of pathogenic bacteria is the pri-mary reservoir for maintaining bacterial species within a
population (7) and is considered a prerequisite for development
of major childhood diseases, including bacterial pneumonia,
meningitis, and otitismedia. Streptococcus pneumoniae is themost
common bacterial cause of childhood pneumonia and is respon-
sible for at least 800,000 child deaths annually, primarily in devel-
oping countries (18, 33). While rarely fatal, otitis media is the
most frequently reported childhood bacterial infection: approxi-
mately 80% of children experience otitis media by age three (17).
S. pneumoniae,Haemophilus influenzae, andMoraxella catarrhalis
are the predominant causes of otitis media (36).
PCV7 (Prevnar; Pfizer Inc.) effectively reduces carriage and
subsequent disease caused by the serotypes of S. pneumoniae in-
cluded in the vaccine. However, pneumococcal vaccination has
minimal impact on the overall rate of pneumococcal carriage due
to replacement by nonvaccine serotypes (3, 8, 11). Reports dem-
onstrating an inverse relationship between nasopharyngeal car-
riage of vaccine type S. pneumoniae and Staphylococcus aureus (2,
21, 22) and increases in the proportion of otitis media caused by
nontypeable H. influenzae following PCV7 vaccination (1, 4, 41)
generated concern that removal of vaccine type pneumococci
from the nasopharynx could facilitate colonization by other respi-
ratory pathogens. This study aimed to evaluate the effects of pneu-
mococcal immunization on carriage of respiratory pathogens in a
high-risk population.
A quantitative real-time PCR (qPCR) method was developed
to measure S. pneumoniae, H. influenzae, M. catarrhalis, and S.
aureus and applied to nasopharyngeal swabs collected from 17-
month-old participants in a phase II pneumococcal vaccine trial
in Suva, Fiji. The trial investigated appropriate infant dosing strat-
egy of PCV7 and effects of a 23-valent polysaccharide (23vPPS;
Pneumovax; Merck & Co., Inc.) booster given at 12 months. En-
rollment, ethical approval, and swab collection and storage have
been detailed previously (25, 27, 29). Swabs (collected in 2006 and
2007) in STGG media (19) were transported to Melbourne, Aus-
tralia, on dry ice and stored at 80°C until use. The following
sample groups were examined: group A (n  54), who received
three doses of PCV7 at 6, 10, and 14 weeks of age; group B (n 
48), who received three PCV7 doses plus a booster of 23vPPS at 12
months of age; and group H (n  59), who were unvaccinated.
Previous examination of pneumococcal serotypes showed that
three doses of PCV7 led to a reduction in carriage of vaccine type
S. pneumoniae that was sustained to the age of 17months, whereas
carriage rates of non-PCV serotypes were similar, and that 23vPPS
had no impact on carriage (27).
Cells from a 100-l aliquot of sample were lysed in 200l of 50
mM phosphate buffer, pH 6.7, containing 1 mg/ml lysozyme,
0.075 mg/ml mutanolysin, and 2 mg/ml proteinase K and incu-
bated at 56°C for 45min. An additional 2mg/ml proteinase K and
1% SDS were added, and then cells were incubated at 56°C for 10
min. DNA was extracted and purified into 100 l elution buffer
using the QIAmp DNA minikit (Qiagen). DNA for standard
curves was extracted from S. pneumoniae ATCC 6305,H. influen-
zae F412 (kindly provided by Cynthia Whitchurch, University of
Technology, Sydney, Australia), S. aureus ATCC 29213, and M.
catarrhalis ATCC 8176. We developed two quantitative duplex
PCR assays, one to detect S. pneumoniae and S. aureus and another
to detect H. influenzae and M. catarrhalis. S. pneumoniae was de-
tected using previously published primers and probes (30). Prim-
ers for S. aureus detection were modified for use with a previously
published probe (6) for enhanced sensitivity. Sequence alignment
ofM. catarrhalis copB from 14 available GenBank entries revealed
that published probes (9, 30) hybridize to a variable region of the
gene, so a newprimer/probe set was designed to target a conserved
region of this gene. This qPCR was coupled with an assay for H.
influenzae that was developed to detect both typeable and non-
typeable H. influenzae but not the closely related Haemophilus
haemolyticus (38). Two microliters of DNA was used in each of
two duplex qPCRs performed with Brilliant III Ultra-Fast QPCR
master mix (Agilent Technologies) on a Stratagene Mx3005 real-
time PCR instrument with an initial activation of 95°C for 3 min
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followed by 40 cycles of 95°C for 20 s and 60°C for 20 s. Table 1
details PCR primers (Sigma-Aldrich) and dually labeled probes
(Eurogentec).
qPCR data were used to determine the carriage rate (% posi-
tive) and carriage density (CFU/ml) for each bacterial species.
Fisher’s exact test and the Mann-Whitney test were used to eval-
uate differences in rate and density, respectively. P values 0.05
were considered statistically significant. Associations were mea-
sured by calculating odds ratios (OR) and 95% confidence inter-
vals (CI 95%).
Of the 161 NP swabs examined, at least one pathogen was
identified in 141 (87.5%). M. catarrhalis was identified most fre-
quently, found in 122 (75.8%) swabs, followed by S. pneumoniae
(n  92; 57.1%) and H. influenzae (n  72; 44.7%). The overall
carriage rate of S. aureus, 3.3%, was consistent with reports from
the Gambia (12) and Western Australia, Australia (39). S. aureus
carriage is typically highest in neonates and older children (2, 22,
23), and the nose, rather than the nasopharynx, is the primary
ecological niche (40). Due to its low frequency, S. aureus was not
included in subsequent analyses. The higher colonization rates of
S. pneumoniae, H. influenzae, and M. catarrhalis were similar to
those observed in high-risk populations (12, 16, 30, 39). Cocolo-
nization was common, with 97 of 161 (60.2%) children colonized
bymultiple species comparedwith 44 (27.3%) colonized by one of
the species tested. Positive associations between colonization by S.
pneumoniae andM. catarrhalis (OR, 3.16; CI 95%, 1.49 to 6.71), S.
pneumoniae and H. influenzae (OR, 3.85; CI 95%, 1.95 to 7.58),
and M. catarrhalis and H. influenzae (OR, 6.70; CI 95%, 2.70 to
17.60) were found.
Regardless of 23vPPS booster status, vaccination with PCV7
did not affect carriage rates (Table 2) or densities (data not shown)
of the four pathogens examined. The population of Fiji consists of
57% indigenous Fijians and 38% Indo-Fijians of Indian descent.
The original vaccine trial was designed to approximate this break-
down in each vaccine group. As indigenous Fijian children are
known to have higher rates of S. pneumoniae carriage (26), data
were stratified by ethnicity and reanalyzed. Swabs from groups A,
B, and H were collected from 99 Fijians and 54 Indo-Fijians (eth-
nicity self-reported upon enrollment). Indigenous Fijians (i) were
more likely to carry two or more organisms (OR, 9.66; CI 95%,
4.49 to 20.77), (ii) had significantly higher carriage rates of S.
pneumoniae, H. influenzae, and M. catarrhalis (Table 2), and (iii)
had higher carriage densities of S. pneumoniae and M. catarrhalis
(Fig. 1) than Indo-Fijians.
Next, we examined the effects of pneumococcal vaccination
separately for each ethnic group. No differences in carriage rates
were observed (data not shown). Vaccination did not affect car-
riage densities of S. pneumoniae or H. influenzae in either indige-
nous Fijians or Indo-Fijians (Fig. 2A and B). Carriage densities of
M. catarrhalis were significantly higher in indigenous Fijian chil-
dren who received three doses of PCV7 plus a 23vPPV booster
than in thosewhowere unvaccinated or received PCV7 alone (Fig.
2C). This increase in M. catarrhalis density was not observed in
Indo-Fijian children.
In summary, vaccination of Fijian infants with PCV7 alone or
with the 23vPPS booster did not affect nasopharyngeal carriage
rates or densities of S. pneumoniae, H. influenzae, M. catarrhalis,
and S. aureus. However, significant differences between the two
major ethnic groups were found, with indigenous Fijians more
likely to carry higher densities of multiple respiratory pathogens
than Fijians of Indian descent.
Several studies investigated effects of pneumococcal vaccina-
tion on S. aureus, and most did not find any increases in S. aureus
colonization associated with PCV7 (4, 5, 13) or PCV9 (14) vacci-
TABLE 1 Sequences and concentrations of primers and probes for duplex quantitative PCRs to detect S. pneumoniae and S. aureus (reaction 1) and
M. catarrhalis and H. influenzae (reaction 2)
Reaction
Species and target
gene Primer and probe sequencesa (5=–3=) [concn (nM)]
Reference
and/or source
1 S. pneumoniae lytA F, TCTTACGCAATCTAGCAGATGAAGC [96]; R, GTTGTTTGGTTGGTTATTCGTGC [96]; probe,
FAM-TTTGCCGAAAACGCTTGATACAGGG-BHQ1 [96]
30
S. aureus nuc F, GTTGCTTAGTGTTAACTTTAGTTGTA [288]; R, GCACTATATACTGTTGGATCTTCAGAA
[288]; probe, TxR-TGCATCACAAACAGATAACGGCGTAAATAGAAG-BHQ2 [192]
6, this study
2 M. catarrhalis copB F, CGTGTTGACCGTTTTGACTTT [96]; R, TAGATTAGGTTACCGCTGACG [96]; probe, Cy5-AC
CGACATCAACCCAAGCTTTGG-BHQ3 [96]
This study
H. influenzae hpd F, GGTTAAATATGCCGATGGTGTTG [96]; R, TGCATCTTTACGCACGGTGTA [288]; probe,
HEX-TTGTGTACACTCCGT“T”GGTAAAAGAACTTGCAC-SpacerC3b [96]
38
a F, forward; R, reverse; FAM, 6-carboxyfluorescein; BHQ1, black hole quencher 1; TxR, Texas red; HEX, hexachloro-6-carboxyfluorescein.
b “T”, BHQ-1 (dT).
TABLE 2 Nasopharyngeal carriage rates of S. pneumoniae, H. influenzae, and M. catarrhalis in Fijian children stratified by vaccine
group and ethnicity
Species
No. of positive samples/total no. of samplesa (%) for:
Vaccine group
Fijian group Indo-Fijian group3 doses PCV7 3 doses PCV7 23vPPV No vaccine
S. pneumoniae 30/54 (56) 29/48 (60) 33/59 (56) 68/99 (69) 20/54 (37)
H. influenzae 24/54 (44) 24/48 (50) 24/59 (41) 66/99 (67) 6/54 (11)
M. catarrhalis 42/54 (78) 39/48 (81) 41/59 (70) 91/99 (92) 24/54 (44)
a , P 0.001. For all other comparisons, P was0.05.
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nation. In contrast, vanGils et al. reported a temporary increase in
S. aureus colonization at 12months of age in infants who received
three doses of PCV7 (34). The low carriage rate of S. aureus in our
study hindered our ability to assess the impact of pneumococcal
vaccination on its carriage in Fijian infants. Reported increases in
the proportion of otitis media caused by H. influenzae and M.
catarrhalis associated with PCV7 vaccination (1, 4, 41)may reflect
the reduction in cases caused by vaccine type S. pneumoniae rather
than true increases in disease caused by other pathogens. For ex-
ample, Stamboulidis et al. noted that, following PCV7 immuniza-
tion, the overall rate of acute otitis media with otorrhea and the
incidence of S. pneumoniae- and H. influenzae-caused otorrhea
declined, yetH. influenzae replaced S. pneumoniae as the predom-
inant organism (31).
Revai et al. examined nasopharyngeal colonization during
acute otitis media and found an increase in M. catarrhalis in
PCV7-vaccinated children compared with unvaccinated histori-
cal controls (24). Consistent with our findings, studies on the
effects of pneumococcal vaccination in healthy children found no
increases in carriage of H. influenzae (14, 35) or M. catarrhalis
(35). We used the final swabs collected during the study, taken at
17 months, 14 months after the last dose of PCV7 and 5 months
after the 23vPPS booster. Therefore, any transient effects of pneu-
mococcal vaccination would not have been observed in this study.
We found strong positive associations between carriage of S.
pneumoniae, H. influenzae, and M. catarrhalis. Other researchers
have reported similar associations between S. pneumoniae andH.
influenzae (10, 12, 14), S. pneumoniae andM. catarrhalis (10, 12),
andM. catarrhalis andH. influenzae (10, 37) in children of a com-
parable age. Pettigrew et al. (20) found negative associations be-
tween S. pneumoniae andH. influenzae and betweenM. catarrhalis
and H. influenzae in children with upper respiratory infections,
suggesting that the presence of an active infection may influence
colonization dynamics. In our study, attributes of the host rather
FIG 1 Nasopharyngeal carriage densities of S. pneumoniae (S. pneu),H. influ-
enzae (H. inf), and M. catarrhalis (M. cat) in indigenous Fijian (Fijian) and
Indo-Fijian infants. The median and interquartile ranges are shown in gray. ,
P 0.05. For all other comparisons, P was0.05.
FIG 2 Nasopharyngeal carriage densities of S. pneumoniae (A),H. influenzae (B), andM. catarrhalis (C) separated by vaccine group and ethnicity. The median
and interquartile ranges are shown in gray. , P 0.01. For all other comparisons, P was0.05.
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than the presence of a particular bacterial species seemed to be the
dominant factor relating to the cocarriage of multiple pathogens.
Host immunity likely plays a role in the negative association be-
tween S. aureus and S. pneumoniae, as this inverse relationshipwas
not observed in HIV-positive children (14).
Indigenous Fijians have been shown to have higher incidence
of pneumonia (15), invasive pneumococcal disease (28), and
group A streptococcal disease (32) than Indo-Fijians. Reasons for
this are unclear but may include genetic susceptibility, cultural
practices, and/or environmental factors such as crowded living
conditions. In our study, antibiotic use and monthly annual in-
come levels were similar between the ethnicities but Fijian families
had more children under 5 in the household, a risk factor for S.
pneumoniae colonization (26). Differences in carriage between
ethnic groups raise the possibility that vaccines targeting coloniz-
ing bacteria may have differential effects in different populations.
Indeed, the 23vPPS booster was associated with increased carriage
densities of M. catarrhalis in indigenous Fijians but not Indo-
Fijians. Differences in susceptibilities to bacterial colonization
warrant further investigation, and the high levels of carriage of
multiple pathogens common in developing countries should be
taken into consideration when designing and monitoring new
pneumococcal vaccine introduction.
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